Biotech Outlook 2010

Monitoring & improving the red biotech cluster

 

The Nyenrode LSH |Biotech Outlook aims to further increase the overall success of the Dutch ‘red biotech’ sector. Red biotech is the biotechnology with applications in health care. The Biotech Outlook contributes by monitoring the performance and progress of the Dutch red biotech cluster and by giving recommendations for further improvement.

 

  •         Structure and content
  •        Performance and progress
  •         Key recommendations

 

Request the management summary or the full Biotech Outlook report here (PDF).

 

LS&H Initiative

The Biotech Outlook 2010 is an initiative of the Life Scienes & Health Program and Nyenrode Life Sciences & Healthcare  Institute, part of the Nyenrode Business University and strategy consulting firm The Decision Group. The Outlook is part of the Life Sciences & Health Innovation Program.

 

Presentation of the Nyenrode LSH | Biotech Outlook

The Outlook was presented on January 20th to 50 experts from the red biotech cluster after which the proposed actions and recommendations were discussed.